…
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Clarivate plc provides information, analytics and workflow solutions for scientific research, patent and intellectual property management and regulatory intelligence through subscription and services offerings. Long-term growth may be supported by rising demand for data-driven R&D and IP management, expansion of analytics and AI-enabled tools, and cross-selling into a global customer base, and the company appears positioned to benefit from a high proportion of recurring revenue and scale in niche data markets.
Key risks include significant financial leverage that could limit flexibility, competitive pressure from alternative data and analytics providers, and execution risk integrating acquisitions and expanding AI capabilities.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -193.90M | -553.80M | -1012.50M | -3989.10M | -3989.10M |
| Net income | -201.10M | -636.70M | -911.20M | -3960.20M | -3960.20M |
| Selling general administrative | 708.60M | 727.60M | 739.90M | 729.90M | 553.76M |
| Gross profit | 1621.60M | 1687.50M | 1722.40M | 1705.80M | 1705.80M |
| Reconciled depreciation | 757.20M | 727.00M | 716.30M | 710.50M | 537.82M |
| Ebit | 71.50M | -270.40M | -718.80M | 590.20M | 590.20M |
| Ebitda | 828.70M | 456.60M | -10.50M | 1300.70M | 1300.70M |
| Depreciation and amortization | 757.20M | 727.00M | 708.30M | 710.50M | 710.50M |
| Non operating income net other | - | - | - | 206.80M | -205.06M |
| Operating income | 71.50M | -275.60M | -734.70M | -3925.60M | 590.20M |
| Other operating expenses | 2383.70M | 2832.30M | 3363.50M | 2069.60M | 2069.60M |
| Interest expense | 265.40M | 283.40M | 293.70M | 270.30M | 270.30M |
| Tax provision | 7.20M | 82.90M | -161.10M | -28.90M | 12.30M |
| Net interest income | -265.40M | -283.40M | -295.50M | -270.30M | -252.49M |
| Non recurring | - | - | - | 4515.80M | 56.14M |
| Income tax expense | 7.20M | 82.90M | -101.30M | -28.90M | -28.90M |
| Total revenue | 2455.20M | 2556.70M | 2628.80M | 2659.80M | 2659.80M |
| Total operating expenses | 1550.10M | 1963.10M | 2457.10M | 1115.60M | 1115.60M |
| Cost of revenue | 833.60M | 869.20M | 906.40M | 954.00M | 954.00M |
| Total other income expense net | -265.40M | -278.20M | -277.80M | -4309.00M | -4579.30M |
| Net income from continuing ops | -201.10M | -636.70M | 256.10M | -3960.20M | -350.62M |
| Net income applicable to common shares | - | - | - | -4035.60M | -350.62M |
| Preferred stock and other adjustments | - | - | - | 75.40M | 41.51M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 11069.40M | 11490.20M | 12706.80M | 13944.90M | 13944.90M |
| Intangible assets | 8008.10M | 8441.20M | 9006.60M | 9437.70M | 9437.70M |
| Other current assets | 159.10M | 151.10M | 271.70M | 76.90M | 76.90M |
| Total liab | 6226.50M | 6351.20M | 6714.50M | 7132.40M | 7132.40M |
| Total stockholder equity | 4842.90M | 5139.00M | 5992.30M | 6812.50M | 6812.50M |
| Deferred long term liab | - | - | - | 316.10M | 367.00M |
| Other current liab | 419.70M | 322.60M | 424.00M | 484.20M | 484.20M |
| Common stock | 12810.60M | 12978.80M | 11740.50M | 11744.70M | 11744.70M |
| Capital stock | 12810.60M | 12978.80M | 13133.10M | 13137.30M | 13220.53M |
| Retained earnings | -7514.60M | -7313.50M | -6645.50M | -5658.90M | -5658.90M |
| Other liab | - | - | - | 494.70M | 804.90M |
| Good will | 1566.70M | 1566.60M | 2023.70M | 2876.50M | 2876.50M |
| Other assets | - | - | 0.00M | 122.10M | 78.65M |
| Cash | 329.20M | 295.20M | 370.70M | 348.80M | 348.80M |
| Total current liabilities | 1568.80M | 1433.50M | 1600.00M | 1559.80M | 1559.80M |
| Current deferred revenue | 878.60M | 943.90M | 983.10M | 947.50M | 947.50M |
| Net debt | 4150.10M | 4297.30M | 4438.00M | 4755.80M | 4755.80M |
| Short term debt | 119.90M | 42.50M | 48.80M | 26.70M | 26.70M |
| Short long term debt | 101.50M | 1.30M | - | 1.00M | 30.58M |
| Short long term debt total | 4479.30M | 4592.50M | 4808.70M | 5104.60M | 5104.60M |
| Other stockholder equity | - | - | 1392.60M | 13137.30M | -16.96M |
| Property plant equipment | - | - | - | 113.40M | 169.88M |
| Total current assets | 1310.00M | 1244.60M | 1462.20M | 1395.20M | 1395.20M |
| Net tangible assets | - | - | - | 5419.90M | -4378.52M |
| Short term investments | - | - | 2.30M | - | - |
| Net receivables | 821.70M | 798.30M | 908.30M | 872.10M | 872.10M |
| Long term debt | 4321.50M | 4518.70M | 4721.10M | 5005.00M | 3457.90M |
| Inventory | - | - | -88.50M | 97.40M | 97.40M |
| Accounts payable | 150.60M | 124.50M | 144.10M | 101.40M | 101.40M |
| Accumulated other comprehensive income | -453.10M | -526.30M | -495.30M | -665.90M | -665.90M |
| Common stock total equity | - | - | - | 11744.70M | 9989.28M |
| Preferred stock total equity | - | - | - | 1392.60M | 1392.62M |
| Retained earnings total equity | - | - | - | -5658.90M | -1250.84M |
| Non currrent assets other | 68.10M | 67.50M | 43.10M | 97.90M | 97.90M |
| Non current assets total | 9759.40M | 10245.60M | 11244.60M | 12549.70M | 12549.70M |
| Capital lease obligations | 56.30M | 73.80M | 87.60M | 98.60M | 126.13M |
| Long term debt total | - | - | - | 5005.00M | 3457.90M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -236.70M | 57.70M | 57.30M | -4044.46M |
| Change to liabilities | - | - | - | -162.20M | -54.08M |
| Total cashflows from investing activities | -263.20M | -236.70M | -237.40M | 57.30M | -2988.77M |
| Net borrowings | -100.00M | -198.10M | -300.00M | -498.60M | -115.94M |
| Total cash from financing activities | -343.10M | -470.10M | -496.50M | -759.20M | -759.20M |
| Change to operating activities | - | - | - | -210.30M | 100.75M |
| Net income | -201.10M | -636.70M | -911.20M | -3960.20M | -3960.20M |
| Change in cash | 34.00M | -75.50M | 13.90M | -230.80M | -230.80M |
| Begin period cash flow | 295.20M | 370.70M | 356.80M | 587.60M | 587.60M |
| End period cash flow | 329.20M | 295.20M | 370.70M | 356.80M | 356.80M |
| Total cash from operating activities | 628.50M | 646.60M | 744.20M | 509.30M | 509.30M |
| Issuance of capital stock | - | - | 3.50M | 5.70M | 2260.52M |
| Depreciation | 757.20M | 727.00M | 708.30M | 710.50M | 710.50M |
| Other cashflows from investing activities | -263.20M | 84.40M | 285.00M | 260.20M | -2881.05M |
| Dividends paid | 0.00M | 37.70M | 75.50M | -75.40M | -75.40M |
| Change to inventory | - | - | -210.30M | -210.30M | 100.75M |
| Change to account receivables | -5.00M | 92.60M | -25.50M | -28.30M | -28.30M |
| Sale purchase of stock | -224.50M | -200.00M | -100.00M | -175.00M | -175.00M |
| Other cashflows from financing activities | -9.20M | -34.30M | -20.00M | -16.10M | -16.10M |
| Change to netincome | - | - | - | 4014.50M | 175.67M |
| Capital expenditures | 263.20M | 289.10M | 242.50M | 202.90M | 202.90M |
| Change receivables | - | - | - | -28.30M | 29.95M |
| Cash flows other operating | - | - | - | -65.00M | 159.43M |
| Cash and cash equivalents changes | - | - | - | -192.60M | 201.31M |
| Change in working capital | 3.50M | -24.90M | -60.40M | -271.90M | -271.90M |
| Stock based compensation | 63.10M | 59.90M | 109.00M | 93.90M | 93.90M |
| Other non cash items | 625.00M | 500.10M | 976.90M | 3991.30M | 3991.30M |
| Free cash flow | 365.30M | 357.50M | 501.70M | 306.40M | 306.40M |
Sector: Technology Industry: Information Technology Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CLVT CLARIVATE PLC |
- -% |
2.34 | - | 2.67 | 0.50 | 0.27 | 2.18 | 7.90 |
| IBM International Business Machines |
-2.11 0.85% |
245.00 | 22.06 | 18.73 | 3.39 | 6.81 | 4.22 | 16.61 |
| ACN Accenture plc |
- -% |
260.50 | 16.00 | 14.29 | 1.66 | 3.84 | 1.65 | 9.80 |
| INFY Infosys Ltd ADR |
-0.30 2.34% |
12.50 | 25.55 | 22.78 | 4.20 | 8.01 | 4.10 | 15.87 |
| FJTSF Fujitsu Limited |
- -% |
21.93 | 21.97 | 14.84 | 0.01 | 3.44 | 1.86 | 11.66 |
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Jonathan M. Collins | Exec. VP & CFO | 1980 |
| Mr. Gordon Samson | Chief Product Officer | 1966 |
| Mr. Steen Lomholt-Thomsen | Chief Revenue Officer | 1964 |
| Mr. Jonathan Gear | CEO & Director | 1971 |
| Mr. Michael Easton | Sr. VP of Fin. & Chief Accounting Officer | 1973 |
| Mr. Stefano Maestri | Chief Technology Officer | NA |
| Mr. William E. Graff | Chief Information Officer | NA |
| Mr. Mark J. Donohue | Head of Investor Relations | NA |
| Ms. Jaspal Chahal | Chief Legal Officer & Gen. Counsel | 1966 |
| Mr. Ed Mattix | Chief Global Communications & Brand Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.